抗体-寡核酸结合物的结构-活性关系:评估抗体-siRNA结合物的生物结合策略,用于药物开发
Michael Cochran1, Danny Arias1, Rob Burke1
1Avidity Biosciences, Inc., 10578 Science Center Drive Suite 125. San Diego, California 92121, United States.
Journal of medicinal chemistry
|August 28, 2024
概括
优化抗体-寡核酸结合物用于肝外输送需要仔细选择siRNA化学,结合部位和药物对抗体比率 (DAR). 这些因素对药理动力学,siRNA传递和mRNA敲击 (KD) 产生重大影响,以提高治疗疗效.
科学领域:
- 生物结合科学是生物结合的科学.
- 治疗性输送系统治疗性输送系统
- 分子生物学分子生物学
背景情况:
- 抗体-寡核酸结合体有可能通过肝外输送小干扰性核糖核酸 (siRNAs).
- 优化这些结合体需要理解结构-活性关系,以改善传递和mRNA敲击 (KD).
研究的目的:
- 系统地检查影响抗体-siRNA结合性质的因素.
- 确定优化生物结合,药理动力学 (PK),siRNA递送和生物活性的关键参数.
主要方法:
- 评估的抗体同型,siRNA化学,链接剂,结合化学,PEGylation和药物对抗体比率 (DAR).
- 评估结合部位 (氨酸,氨酸,Asn297甘氨酸) 以及它们对PK和分娩的影响.
- 研究的siRNA修饰 (2'糖,酸酸盐) 和链接类型 (可切割,不可切割) 用于传递和KD.
主要成果:
- 结合部位和DAR对于最佳的PK和siRNA传递至关重要.
- SiRNA化学,包括2'糖修饰和酸定位,显著影响了输送和持续时间.
- 连接器类型影响了PK和mRNAKD,可切割和不可切割的连接器表现出不同的效果.
结论:
- 为了达到最佳的抗体-siRNA结合物特性,需要一个仔细的,多因素的选择过程.
- 关键参数包括siRNA化学,DAR,结合部位,链接器策略和抗体同型.
- 这种系统的方法对于开发有效的肝外siRNA疗法至关重要.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.4K
相关概念视频
01:10Antibody Structure
59.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.6K
01:25Antibody Structure and Classes
856
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
856
01:28Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:41Affinity and Avidity
35.9K
Overview
35.9K
01:31Hybridoma Technology
14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K